Second workshop for the EMEA/CHMP Working Group with Patients' Organisations

Event

Date: Saturday, 04 December 2004
Location: European Medicines Agency, Amsterdam, the Netherlands

On 3 December 2004, the EMEA/CHMP Working Group with Patients' Organisations held aworkshop with representatives from a number of partners and stakeholders, including theEuropean Commission, national competent authorities, patients' organisations, healthcareprofessionals' organisations and pharmaceutical industry. The objective was to discuss therecommendations and proposals for action published for consultation in April 2004.

Documents

Report from the 2nd workshop for the EMEA /CHMP working group with patients organisations

Reference Number: EMEA/17857/2005 Final

English (EN) (166.56 KB - PDF)

First published: 17/03/2005Last updated: 17/03/2005

Recommendations and proposals for action - Dr Daniel Brasseur

English (EN) (214.33 KB - PDF)

First published: 03/12/2004Last updated: 03/12/2004

Recommendations in the area of pharmacovigilance - Emmanuel Trenado

English (EN) (206.5 KB - PDF)

First published: 03/12/2004Last updated: 03/12/2004

Transparency and dissemination of information - Francois Houyvez

English (EN) (306.57 KB - PDF)

First published: 03/12/2004Last updated: 03/12/2004

General remarks on the recommendations - Dr Frits Lekkerkerker

English (EN) (286.84 KB - PDF)

First published: 03/12/2004Last updated: 03/12/2004

Recommendations in the area of interaction between EMEA CHMP and Patients Organisations - Dr Isabelle Moulon

English (EN) (193.52 KB - PDF)

First published: 03/12/2004Last updated: 03/12/2004

Product information recommendations and proposals for action - Lesley Greene

English (EN) (224.77 KB - PDF)

First published: 03/12/2004Last updated: 03/12/2004